PTEN and metastatic neoplasm: Varying rates of prostatic hyperplasia and cancer are seen in mouse models with heterozygous loss of PTEN [63,64,65,66] and combined deletion of a second tumor suppressor gene can induce prostate cancer with complete penetrance in some models [67]; heterozygous models failed to develop metastatic disease however.